RS

Ramkumar Srinivasan

Active Director Director DIN 00731177
DIN 00731177 First appointment Feb 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Feb 2008
Shareholding value •••• Premium profile

About Ramkumar Srinivasan

Data last updated:

Ramkumar Srinivasan is a Director at Cu-V-Kar Genetic Medicine Private Limited (since 2019), Director at Hfa Formulations Private Limited (since 2021) and Managing Director at Viencee Pharma Science Private Limited (since 2022), and holds 2 more current directorships. The companies operate in Pharma and Paper. The 4 current companies with reported revenue have a combined latest revenue of ₹72.32 Cr; the largest is Cu-V-Kar Genetic Medicine Private Limited at ₹55.11 Cr (FY 2024). Earlier, Ramkumar Srinivasan was a Director at Landsteiner Pharmaceuticals Private Limited (from 2008) and Director at Consonance Technology Solutions Private Limited (from 2019).

DIN 00731177
Primary Designation Director
Industry Pharma
First Appointment 20 Feb 2008
Oldest Company Age 19 yrs
Largest company Cu-V-Kar Genetic Medicine Private Limited · ₹55.11 Cr (FY 2024)
Combined revenue ₹72.32 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Aug 20192007₹55.11 Cr (FY 2024)Active
Hfa Formulations Private Limited U33110TN2015PTC099069
Director29 Apr 20212015₹15.65 Cr (FY 2024)Active
Managing Director21 Mar 20222017₹1.54 Cr (FY 2024)Active
Director05 Jul 20232023₹1.1 Lakh (FY 2025)Active
Mm Pharma Medicines Private Limited U21002TN2023PTC163812
Director20 Sep 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Feb 20082008Strike Off
Director30 Sep 20192008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ramkumar Srinivasan

Directorship timeline

Open interactive timeline →
Cu-V-Kar Genetic Medicine Private Limited
Hfa Formulations Private Limited
Viencee Pharma Science Private Limited
Landsteiner Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramkumar Srinivasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramkumar Srinivasan

Ramkumar Srinivasan currently holds 5 directorships: Cu-V-Kar Genetic Medicine Private Limited (Director, since 09 Aug 2019, revenue ₹55.11 Cr (FY 2024)); Hfa Formulations Private Limited (Director, since 29 Apr 2021, revenue ₹15.65 Cr (FY 2024)); Viencee Pharma Science Private Limited (Managing Director, since 21 Mar 2022, revenue ₹1.54 Cr (FY 2024)); Cu-V-Kar Pharmacuticals Private Limited (Director, since 05 Jul 2023, revenue ₹1.1 Lakh (FY 2025)); Mm Pharma Medicines Private Limited (Director, since 20 Sep 2023).

Ramkumar Srinivasan was first appointed on 20 Feb 2008 as Director at Landsteiner Pharmaceuticals Private Limited. The most recent appointment on record is 20 Sep 2023 at Mm Pharma Medicines Private Limited.

The 4 current companies of Ramkumar Srinivasan that report revenue have a combined latest revenue of ₹72.32 Cr: Cu-V-Kar Genetic Medicine Private Limited ₹55.11 Cr (FY 2024); Hfa Formulations Private Limited ₹15.65 Cr (FY 2024); Viencee Pharma Science Private Limited ₹1.54 Cr (FY 2024); Cu-V-Kar Pharmacuticals Private Limited ₹1.1 Lakh (FY 2025).

Ramkumar Srinivasan held 2 earlier board appointments: Landsteiner Pharmaceuticals Private Limited (Director, from 20 Feb 2008); Consonance Technology Solutions Private Limited (Director, from 30 Sep 2019).

The current boards of Ramkumar Srinivasan's companies include Muthukaruppan Srinivasan (Cu-V-Kar Genetic Medicine Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available